Vitamin C (in the reduced form ascorbate or in the oxidized form dehydroascorbate) is implicated in signaling events throughout the central nervous system (CNS). In the retina, a high-affinity transport system for ascorbate has been described and glutamatergic signaling has been reported to control ascorbate release. Here, we investigated the modulatory role played by vitamin C upon glutamate uptake and Nmethyl-D-aspartate (NMDA) receptor activation in cultured retinal cells or in intact retinal tissue using biochemical and imaging techniques. We show that both forms of vitamin C, ascorbate or dehydroascorbate, promote an accumulation of extracellular glutamate by a mechanism involving the inhibition of glutamate uptake. This inhibition correlates with the finding that ascorbate promotes a decrease in cell surface levels of the neuronal glutamate transporter excitatory amino acid transporter 3 in retinal neuronal cultures. Interestingly, vitamin C is prone to increase the activity of NMDA receptors but also promotes a decrease in glutamate-stimulated 
Vitamin C is a well-known antioxidant and displays several important functions in the central nervous system (CNS) (Yazulla 1985; Englard and Seifter 1986; Eldridge et al. 1987; Majewska et al. 1990; Neal et al. 1999; Kaya et al. 2008; Calero et al. 2011; Meredith and May 2013) . Sodium vitamin C co-transporters (SVCTs) mediate ascorbate transport in different cellular systems while the oxidized form of vitamin C, dehydroascorbate (DHA), is taken up by glucose transporters (Rumsey et al. 1997 (Rumsey et al. , 2000 Mardones et al. 2011) . SVCT-mediated ascorbate transport is performed in a stoichiometric ratio, with two sodium ions for each ascorbate transported (Tsukaguchi et al. 1999; Wilson 2005) . There are two functional transporter isoforms named SVCT1 and SVCT2, which differ in tissue distribution and affinity for ascorbate. SVCT1 is expressed mainly in epithelial organs while SVCT2 is abundant in high metabolic active tissues such as the brain and retina (Castro et al. 2001; Savini et al. 2008) .
Glutamate, the major excitatory CNS neurotransmitter, is removed from the synaptic cleft by excitatory amino acid transporters (EAATs) (Kanai and Hediger 2004) . The EAAT1 and EAAT2 transporter subtypes are expressed in glial cells (Storck et al. 1992; Kanai and Hediger 2004) , while EAAT3 is expressed in neurons and epithelial cells (Kanai and Hediger 1992) . EAAT4 is highly expressed in cerebellar Purkinje cells while EAAT5 is mostly present in the retina (Arriza et al. 1997) . Signaling via glutamate is achieved either through ionotropic (N-methyl-D-aspartate (NMDA), 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid (AMPA) and kainate receptors) or metabotropic receptors (mGluRs, groups I, II, and III). NMDA receptors are functional as tetrameric structures arranged in different glutamate ionotropic receptor subunits (GluN), named GluN1, GluN2A, GluN2B, GluN2C, GluN2D, GluN3A, and GluN3B, which provide different NMDA receptor functionalities such as intracellular calcium transients (Smart and Paoletti 2012; Paoletti et al. 2013) . The activity of NMDA receptors regulates several physiologic processes in the developing or mature CNS, such as long-term potentiation (LTP) formation and memory consolidation (Collingridge and Bliss 1995; Hardingham and Bading 2003; Morgado-Bernal 2011) . Moreover, NMDA receptors regulate the release of different neurotransmitters in the retina (Paes-de-Carvalho et al. 2005; Calaza et al. 2006) , and has been shown to stimulate calcium-dependent signaling pathways, including nitric oxide production (Cossenza and Paesde-Carvalho 2000) , inhibition of protein synthesis (Cossenza et al. 2006 ) and phosphorylation of the transcription factor cAMP response element-binding protein (CREB) (Takeda et al. 2007; Socodato et al. 2009 ). In line with this, we have previously demonstrated that glutamate induces extracellular signal-regulated kinases and CREB phosphorylation in cultured retinal cells, suggesting that this glutamate-regulated activity may have implications in nerve cell development and survival (Socodato et al. 2009 (Socodato et al. , 2011 .
Our previous work have also shown that the activation of glutamate ionotropic receptors increases ascorbate release by a mechanism involving SVCT2 reversion (Portugal et al. 2009 ). In the present work, we analyzed the relationship between vitamin C and NMDA receptor activation and found that ascorbate, as well as the oxidized form DHA, inhibit Daspartate uptake and promote glutamate accumulation at the extracellular space. These effects were more prominent in purified neuronal cultures and accompanied by a decrease in EAAT3 levels. Moreover, vitamin C enhances NMDA receptor activity, but also decreases glutamate-stimulated activity and promotes the internalization of GluN1 NMDA receptor subunits. Both compounds also promote a glutamate receptor and calcium-dependent CREB phosphorylation. These results support the hypothesis that ascorbate is a neuromodulator regulating glutamate signaling in the retina.
Material and methods

Animals
Fertilized White Leghorn chicken eggs were obtained from a local hatchery and incubated at 38°C in a humidified atmosphere up to the appropriate age. All experiments were performed in compliance with ARRIVE guidelines and under institutional approval of COBEA (Ethical principles of animal experimentation) and the Committee on Ethics in Animal Research (CEPA) of the Universidade Federal Fluminense (number 00146/09). The study was not pre-registered.
Materials
Penicillin, streptomycin, L-glutamine, and horseradish peroxidaseconjugated secondary anti-rabbit and anti-mouse antibodies were purchased from Invitrogen (Carlsbad, CA, USA). HEPES, NG-nitro-L-arginine methyl ester, 6,7-dinitroquinoxaline-2,3-dione (DNQX), dimethyl sulfoxide, diamidino-2-phenylindole, dizocilpine maleate (MK-801), sulfinpyrazone, 4 0 ,6-diamidino-2-phenylindole, 1,2-bis-(o-Aminophenoxy)-ethane-N,N,-N',N'-tetraacetic acid tetraacetoxymethyl ester (BAPTA-AM), threo-ß-benzylaspartate (TBA), dehydroascorbic acid, and ascorbic acid were purchased from Sigma Aldrich (St Louis, MO, USA). DL-threo-b-benzyloxyaspartic acid (TBOA) was purchased from Tocris (Bristol, UK). D-[2, 3
3 H] aspartic acid (12.2 Ci/mmol) was purchased from PerkinElmer (Waltham, MA, USA). 2-amino-5-phosphonopentanoic acid was purchased from Biomol (Plymouth Meeting, PA, USA). Glutamic acid and bovine serum albumin were from Calbiochem (San Diego, CA, USA). Fetal bovine serum, trypsin, and minimum essential medium (MEM) were purchased from Gibco (Grand Island, NY, USA). Enhanced chemiluminescence kit, polyvinylidene difluoride membranes, and (+)-[ 3 H] MK-801 (32 Ci/mmol) were purchased from GE Healthcare (Buckinghanshire, UK). Primary antibodies against CREB (RRID: AB_331277) and pCREB (RRID: AB_331276) were from Cell Signaling (Beverly, MA, USA). Alexa488 and Alexa568 conjugated secondary anti-rabbit and anti-mouse antibodies were from Molecular Probes (Eugene, OR, USA). Monoclonal anti-gluN1 (#AB134308) was from Millipore (Billerica, MA, USA) and polyclonal anti-EAAT3 (SLC1A1, C terminal; #SAB4200386) was from Sigma (St. Louis, MO, USA). All other reagents were of analytical grade.
Preparation of retinal cultures
Retinas from 8-day-old chick embryos (E8) were dissected in calcium and magnesium-free Hanks'-balanced salt solution and digested with 0.2% trypsin for 15 min at 37°C. Thereafter, retinal tissue was washed in MEM containing 3% fetal bovine serum supplemented with 100 U/mL penicillin, 100 lg/mL streptomycin and 2 mM glutamine, mechanically dissociated with a Pasteur glasspipette and suspended in MEM. Cells were then seeded onto 24 or 12-well culture plates in a density of 2 9 10 6 cells/mL and maintained in an incubator with 5% CO 2 /95% air ratio. The medium was replaced for fresh supplemented MEM at culture day 1 (C1, 24 h after seeding). When used for western blotting, these cultures were serum-starved at C2 or C3 and experiments were carried out 24 h after serum starvation. Purified cultures of chick embryo retinal neurons were prepared exactly as described elsewhere (Socodato et al. 2011) .
MTT viability assay E8 cultures were incubated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) for 30 min at 37°C after treatment with ascorbate (1.5 mM) for 30 min and then washed twice in Hanks' solution. The dye produced by viable cells was quickly dissolved in acid/alcohol solution [0.6% (v/v) chloridric acid in isopropanol] and the optical density was measured at 570 and 670 nm. The difference between the optical density measured at 570 nm and 670 nm was considered as the result of cell viability.
Western blotting
For detection of protein levels, cultures were washed 39 with Hanks', homogenized and the protein was measured by the Bradford method. Samples were subjected to 9% sodium dodecyl sulfatepolyacrylamide gel electrophoresis; proteins (30 lg/lane) were transferred to polyvinylidene difluoride membranes using a semidry blotting system (Bio-Rad Laboratories, Hercules, CA, USA). Subsequently, membranes were blocked and incubated overnight with primary antibodies specific for different proteins. In the day after, membranes were washed 39 with Tris-buffered saline (20 mM Tris and 200 mM NaCl; p.H. 7.6), incubated with horseradish peroxidase-conjugated secondary antibodies for 2 h, washed again in Tris-buffered saline and developed using an enhanced chemiluminescence kit. Images were acquired in a ChemiDoc TM XRS+ System (Bio-Rad) and quantified using the ImageLab software (Bio-Rad).
Immunocytochemistry and confocal microscopy
Immunocytochemistry labeling was performed exactly as described elsewhere (Portugal et al. 2012) . Images were acquired using a Zeiss LSM 710 confocal microscope (Carl Zeiss, Oberkochen, Germany) with the same gain, offset, and pinhole aperture parameters for all experimental groups. Afterward, images were developed in xyz 12-bit mode at a resolution of 2048 9 2048 pixels in confocal mode. Next, images were thresholded and exported as raw tiff photomicrographs using the ZEN 2009 software (Carl Zeiss). For quantification of the protein levels, ImageJ Fiji software (Laboratory for Optical and Computational Instrumentation, Madison, WI, U.S.A.) (RRID: SCR_002285) was used. Each cell was circulated creating a Region of Interest, and then the mean fluorescent intensity in gray values was normalized by the area of the cell. At least 50 cells were analyzed in each dish.
Biotinylation assay E8C3 mixed cultures, treated with ascorbate for 30 min, were used in this set of experiments. Briefly, culture medium was removed and cells were washed twice with PBS (137 mM NaCl; 2.7 mM KCl; 1.8 mM KH 2 PO 4 ; 10 mM Na 2 HPO 4 .2H 2 O; 0.9 mM CaCl 2 ; 0.5 mM MgCl 2 ) and incubated with 1 mg/mL of NHS-SS-Biotin â (Thermo Scientific, Waltham, MA, U.S.A.) for 30 min at 4°C in the dark with slight rotation. Next, cells were washed twice with 100 mM glycine-supplemented PBS Ca ++ /Mg ++ and incubated in this same saline for 45 min. Afterward, cells were lysed with ristocetin-induced platelet agglutination-dithiothreitol (DTT) buffer, samples were sonicated (6 pulses of 1 sec at 60 Hz), centrifuged (17 000 g for 10 min at 25°C), the supernatant was collected in new tubes and protein content was determined by the bicinchoninic acid assay method. Total amount of protein in each sample was equalized and samples of 50 lL were separated to serve as input; the remaining samples were incubated with NeutrAvidin TM (Thermo Scientific, Waltham, MA, U.S.A.) (0.2 lL of avidin beads to each microgram of protein in each sample) for 2 h at 4°C with orbital shaking. Next, avidin-sample complexes were centrifuged (2800 g for 3 min) and supernatant was used as the unbound fraction. Resulting pellet was washed in ristocetin-induced platelet agglutination-DTT by mild centrifugation, the complexes were eluted using 29 denaturation solution and boiled for 5 min for complete denaturation. Avidin beads were pelleted by centrifugation (17 000 g for 2 min), biotinylated fractions (supernatants) were collected to new tubes and subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis. MK-801 and incubation for additional 5 min. All conditions were carried out in the presence of 50 lM glycine. After this period, cultures were washed twice with Hanks' and then cells were lysed with water and frozen. After thawing, cultures were homogenized in 0.1 M NaOH for 10 min and the radioactivity in each sample was determined in a liquid scintillation analyzer. Nonspecific binding was defined by subtracting the total radioactivity from that obtained in the presence of unlabeled MK-801.
Measurement of extracellular accumulation of glutamate Extracellular glutamate was measured in cultures by the formation of alpha-ketoglutarate. Cultures were washed twice with Hanks' solution and then incubated for 30 min with 1.5 mM of ascorbate or 1.5 mM DHA and/or 100 lM of TBA. The supernatant was collected for analysis; cell lysates were used to normalize samples by protein content (measured by the Lowry method). Cell lysates were incubated in Tris-acetate (75 mM, pH 8.4) containing 400 lM NAD and 150 lM ADP and basal fluorescence level (Gin) was quantified in a luminometer. Thereafter, glutamate dehydrogenase (1.16 U/mL) was added to samples and the mixtures incubated for 30 min to promote the formation of intracellular alpha-ketoglutarate (Gf), which was again quantified in a luminometer. Final normalized data was plotted as Gf -Gin ratio.
Intact retina experiments (ex vivo model) E8 embryos had their retinas dissected at 4°C and equilibrated in HBSS for 20 min at 37°C. Next, retinas were incubated for 30 min in the presence of 1.5 mM ascorbate and then processed for western blotting or determination of extracellular glutamate as described above.
Statistical analysis
All data were normalized in relation to the control of each group and analyzed as a mean AE SEM. No sample calculations were performed to determine sample size and no randomization was performed in group assignment. No blinding evaluations were performed. For statistical analysis we used One-way Anova and Bonferroni post-test, and Student`s t-test in the GraphPad Prism software version 6.01 (La Jolla, CA, USA).
Results
Vitamin C modulates glutamate uptake There is strong evidence showing the relation between vitamin C and the glutamatergic system (see review by Rebec 2013) . Alongside with this, a previous study demonstrated that glutamate regulates the release of ascorbate through a mechanism involving the reversal of SVCT2 transporter in cultured retinal cells (Portugal et al. 2009 ). To investigate this reciprocal connection between vitamin C and the glutamatergic system, we tested the effect of ascorbate on the uptake of [ 3 H] D-aspartate that, as glutamate, is transported by EAATs with high affinity in retinal neurons (Dunlop and Butera 2006) . As can be observed in Fig. 1(a) , ascorbate significantly decreased [ 3 H] D-aspartate uptake. We also incubated these cultures with TBA or TBOA, compounds know to inhibit EAATs, in absence or presence of ascorbate. We found that TBA (100 lM) decreases [ 3 H] D-aspartate uptake to a similar amount as ascorbate (control 100%; ascorbate 74.9 AE 4.5%; n = 4; TBA 66.3 AE 0.75%; n = 5). Moreover, co-incubation of ascorbate and TBA did not produce any additive effect (ascorbate + TBA 62.9 AE 4.1%; n = 5) (Fig. 1a) . Interestingly, TBOA (100 lM) did promote a much more pronounced inhibition of [ 3 H] D-aspartate uptake by retinal cells than TBA (Fig. 1a) , and ascorbate did not produce any additive effect as well (TBOA 21.7 AE 2.6%; ascorbate + TBOA 18.5 AE 1.7%; n = 5). In addition, the oxidized form of vitamin C, DHA, indeed promoted a similar effect as ascorbate on [ (Fig. 1c) . These experiments show that ascorbate does not change the affinity for D-aspartate, but promotes a decrease in the maximum transport.
Since it is described a differential cellular localization of EAATs in the CNS (EAAT3 is mainly found in neurons, whereas EAAT1 and 2 in glial cells) (Shigeri et al. 2004 ), we performed experiments using purified cultures of chick retinal neurons or glial cells and analyzed whether the inhibition promoted by ascorbate occurs in neurons or glial cells. We observed that, in purified neuronal cultures, ascorbate inhibited [ 3 H] D-aspartate uptake (control 100%; ascorbate 65.3 AE 7.3%; n = 3) but this effect was not significant in purified glial cell cultures (control 100%; ascorbate 85.1 AE 9.1%; n = 4) (Fig. 1d) .
We also analyzed whether the decrease observed in [ 3 H] Daspartate uptake is associated with an increase in extracellular glutamate concentrations. For this purpose we measured the extracellular content of glutamate in cultures treated with ascorbate and observed an increase (control 100%; ascorbate 234.7 AE 27.8%; n = 5) in the medium of cultured retinal cells (Fig. 2a) . Moreover, we also used TBA as a positive control and observed, as expected, that this EAAT inhibitor increased the extracellular glutamate content ( Fig. 2a; 209.2 AE 14.4%; n = 5). Again, when TBA and ascorbate were incubated together, no additive effect was detected ( Fig. 2a; 215 .7 AE 43.5%; n = 5). As expected, the effect of DHA on extracellular glutamate was also significant ( Fig. 2b; 138 .2 AE 9.2%; n = 3).
We also evaluated whether ascorbate could regulate glutamate accumulation in the intact retinal tissue. Figure 2(c) shows that ascorbate indeed promotes a robust glutamate accumulation in the intact retina (337.2 AE 63.5% of increase; n = 3).
To investigate if the decrease in [ 3 H] D-aspartate uptake and increase in extracellular glutamate was due to an increase in cell death, we analyzed cell survival after the 30 min period of incubation with ascorbate. We observed no significative difference between control (CT 100%) and ascorbate treatment (106.4 AE 5.6%; n = 3). Altogether, these data indicate that vitamin C inhibits glutamate uptake in neuronal retinal cells and consequently promotes glutamate accumulation in the extracellular medium.
Ascorbate decreases EAAT3 surface levels in purified neuronal culture As shown in Fig. 1(d) , the inhibition of [ 3 H] D-aspartate uptake by ascorbate was detected in purified cultures of retinal neurons but not in glial cultures, suggesting that the effect was targeted to a glutamate transporter expressed in neurons such as the EAAT3 (Kanai and Hediger 1992) . To further investigate the possibility that ascorbate could be regulating EAAT3, we performed immunocytochemistry experiments in non-permeabilized neurons to evaluate cell surface EAAT3 levels using confocal microscopy. As can be observed in Fig. 3 , neurons treated 30 min with ascorbate decreased membrane surface EAAT3 levels, when compared to control (CT 100%; ascorbate 74.3 AE 7.5%; n = 3) ( Fig. 3a and b) .
Vitamin C activates NMDA receptors and regulates NMDA receptor membrane localization As we observed that ascorbate inhibits glutamate uptake and induces the accumulation of glutamate in the extracellular media of retinal cultures, we decided to analyze whether vitamin C could lead to NMDA receptors activation. We then 3 H] MK-801 binding in this experimental paradigm (control 100%; 154.0 AE 10.3%; n = 9 for ascorbate and 135.9 AE 6.6%; n = 3 for DHA) (Fig. 4a) . These data are in accordance with the hypothesis that vitamin C is promoting the accumulation of extracellular glutamate which by its turn is able to activate NMDA receptor activity. As a positive control for NMDA receptor activation, we stimulated cultured retinal cells with exogenous glutamate (500 lM). As expected, glutamate promoted a much higher increase in [ 3 H] MK-801 binding (control 100%; glutamate 345.9 AE 38.0%; n = 4) (Fig. 4b) . Surprisingly, ascorbate or DHA inhibited the glutamate-stimulated [ 3 H] MK-801 binding to approximately the same level as that observed with ascorbate or DHA alone (glutamate + ascorbate 168.6 AE 14.0; n = 5; glutamate + DHA 139.3 AE 30.7%; n = 3) (Fig. 4b) . These puzzling data suggested that glutamate accumulated in the extracellular medium through the action of ascorbate or DHA could activate the NMDA receptor and rapidly promote channel inactivation or receptor down-regulation. To investigate the possibility that vitamin C regulates membrane NMDA receptor levels, we first measured the GluN1 subunit protein levels. After stimulation with ascorbate for 30 min, total GluN1 subunit levels were unchanged (105 AE 7.5%; n = 3) ( Fig. 5a and b) . In order to study whether ascorbate was able to regulate GluN1 subunits traffic to cell membrane, we performed biotinylation experiments for this subunit. We found that GluN1 protein levels reduced at the plasma membrane of ascorbate-treated cultures (58.1 AE 1.5%; n = 3) ( Fig. 5c and d) . To corroborate these data, we performed immunocytochemistry for this subunit coupled to confocal microscopy in non-permeabilized retinal cells and evaluated the expression of GluN1 subunits at the cell surface. As can be observed in Fig. 5(e) and (f), treatment of cultured retinal cells with ascorbate clearly reduced the surface expression of GluN1 subunits (72.9 AE 2.7%; n = 3).
Vitamin C regulates CREB phosphorylation via NMDA receptors The data presented above indicate that vitamin C inhibits glutamate uptake and promotes the accumulation of extracellular glutamate which by its turn activates NMDA receptors. On the other hand, vitamin C is also capable of decreasing NMDA receptor activity induced by glutamate as well as the surface expression of NMDA receptors. Our previous work demonstrated, in the same paradigm, that glutamate increases CREB phosphorylation through the activation of ionotropic glutamate receptors (Socodato et al. 2009 ). We then analyzed whether ascorbate was capable of regulating CREB phosphorylation in retinal cultures. We observed an increase in pCREB level after 5 min of ascorbate administration (from 100% to 144.1 AE 14%; n = 9). After 15 min, stimulation was maximal (from 100% to 220.1 AE 55.8%; n = 6) and remained constant up to 60 min ( Fig. 6a and b) .
A remaining question in our study was whether ascorbateinduced pCREB increase was due to the well-known antioxidant property of ascorbate. To investigate this possibility, we tested other antioxidant molecules such as glutathione or DTT. Cultured retinal cells were incubated for 30 min with each of those substances at the same concentration as ascorbate (1.5 mM). We observed that the antioxidants glutathione or DTT had no significant effect on the pCREB level (control 100%; glutathione 91.6 AE 6.3%; n = 3; DTT 85.0 AE 12.8%; n = 4) ( Fig. 6c and d) , demonstrating that the primary effect of ascorbate in regulating CREB phosphorylation is specifically related with a vitamin C intrinsic property and not to its general antioxidant function. As expected, we also observed that DHA was capable of increasing pCREB level to the same extent as ascorbate ( Fig. 6c and d ; control 100%; DHA 149.6 AE 16.0%; n = 3).
To further validate our in vitro data, we evaluated whether ascorbate-induced pCREB increase also occurs in a more complex paradigm, the ex vivo retinal model. Figure 6 (e) and (f) show that ascorbate significantly increases pCREB levels (control 100%; ascorbate 141.6 AE 14.9%; n = 3) in the intact retina, suggesting a role of ascorbate in regulating CREB function in this tissue. To investigate more precisely the cellular localization of pCREB increase induced by Fig. 2 Vitamin C promotes the accumulation of glutamate at the extracellular space. (a) E8C3 cultures were incubated in Hanks' for 30 min in the absence (control, CT) or presence of ascorbate (1.5 mM; n = 5) and/or threo-ß-benzylaspartate (TBA) (50 lM; n = 5). The saline solution was collected and the glutamate content was estimated as described in the methods section. (b) E8C3 cultures were incubated for 30 min in the absence (control, CT) or presence of dehydroascorbate (DHA) (1.5 mM; n = 3) and then processed as in (a). (c) Intact ex vivo retinas from 12-day-old chick embryos were incubated for 30 min in the absence (control, CT) or presence of ascorbate (1.5 mM; n = 3) and then processed as in (a). (d) E8C3 cultures were incubated for 30 min in the absence (control, CT) or presence of ascorbate (1.5 mM; n = 3) and then cell survival was determined by the MTT assay. Each n represents the mean AE SEM of independent cultures analysed in duplicates. *p < 0.05, **p < 0.01 in relation to control (CT).
ascorbate, we performed immunocytochemistry experiments. Figure 7 (a) shows that ascorbate strongly increases pCREB localization in cell nuclei. We also analyzed the total pCREB fluorescence intensity and observed an increase when compared to control (CT 100%; ascorbate 178.7 AE 4.7; n = 3) (Fig. 7b) .
Our next step was to test whether ascorbate-induced pCREB increase occurred via glutamate receptors. For this purpose, we selectively inhibited those receptors with MK-801, an NMDA receptor channel blocker, or DNQX, an AMPA/Kainate receptor antagonist. We observed that while MK-801 completely inhibited the ascorbate effect ( Fig. 8a  and b ; control 100%; ascorbate 195.7 AE 10.9%; n = 17; ascorbate + MK-801 116.2 AE 35.1%; n = 4), an apparent smaller inhibition was observed with DNQX (138.7 AE 33.4%; n = 4), suggesting that the accumulation of glutamate in the extracellular medium induced by ascorbate activates both types of receptors to increase CREB phosphorylation. One important question was whether the ascorbate-induced pCREB increase was dependent on its uptake in cultured retinal cells. As can be noted in Fig. 8(a) and (b), the ascorbate uptake blocker sulfinpyrazone had no effect on ascorbate-induced pCREB increase (200.5 AE 49.2%; n = 4), indicating that ascorbate uptake is not necessary for increasing pCREB levels in cultured retinal cells.
We then investigated the signaling pathway involved in this ascorbate-regulated and glutamate receptor-dependent increase in pCREB level in retinal cells. Since a classical pathway to increase pCREB levels is through calciumcalmodulin kinases (CaMK) (Sun et al. 1994; Choe and Wang 2001) we used BAPTA-AM (an intracellular calcium chelating agent) and KN 62 (an inhibitor of calcium/ calmodulin-dependent kinases). Both substances inhibited the increase in pCREB level (control 100%; ascorbate 195.7 AE 10.9%; ascorbate + BAPTA-AM 126.2 AE 25.9%; n = 5; ascorbate + KN 62 112.4 AE 10.6%; n = 4) induced by ascorbate (Fig. 8c and d) , implying that ascorbateinduced pCREB increase occurs via NMDA and/or AMPA Fig. 3 Ascorbate decreases excitatory amino-acid transporter 3 (EAAT3) cell surface levels in neurons. (a and b) E8C3 purified neuronal cultures were incubated in the absence (control, CT, n = 3) or presence of ascorbate (1.5 mM; n = 3) for 30 min and then processed for immunocytochemistry using antibody against EAAT3, phalloidin for actin staining and 4 0 ,6-diamidino-2-phenylindole (DAPI) for nuclear staining. Arrows indicate cells with decreased EAAT3 levels. Each n represents the mean AE SEM of independent cultures. At least 50 cells were analysed in each culture. **p < 0.01 in relation to control. Calibration bar = 10 lm. E8C3 cultures were pretreated with glutamate (500 lM; n = 4) and/or ascorbate (1.5 mM; n = 5) or DHA (1.5 mM; n = 3) and then evaluated as in (a). Each n represents the mean AE SEM of independent cultures analysed in duplicates. *p < 0.05, **p < 0.01, ***p < 0.0001 in relation to control.
kainate receptors in a calcium and calcium/calmodulin kinase-dependent manner.
Discussion
Ongoing evidence shows the existence of a link between ascorbate and glutamate functions in the CNS (reviewed in Rebec 2013). We unveil here a chain of events triggered by vitamin C in the retina. We found that ascorbate or DHA partially activate NMDA receptors, but also decrease glutamate-stimulated NMDA receptor activity, decrease GluN1 subunits cell surface expression and increase CREB phosphorylation in a glutamate receptor and calcium-dependent manner. An important clue to explain those results was the finding that vitamin C decreases glutamate uptake, suggesting that all the above mentioned effects are triggered by the accumulation of extracellular glutamate. This inhibitory effect on glutamate uptake correlates with a decrease in cell surface EAAT3 levels in retinal neurons promoted by ascorbate.
Ascorbate modulates glutamate uptake and extracellular accumulation Accumulated evidence suggests that ascorbate is actively coupled to the modulation of both glutamate and dopamine signaling systems in the neostriatum (Rebec and Pierce 1994) . In line with this, the prime effect exerted by ascorbate in glutamate transport was correlated with the modulation of an ascorbate-glutamate heteroexchanger in striatal neurons (Rebec and Pierce 1994) . However, glutamate-induced ascorbate release in cultured retinal cells involves the reversal of SVCT2 mediated by activation of ionotropic glutamate receptors (Portugal et al. 2009 ). On the other hand, we reported here using the same culture paradigm, that ascorbate and DHA inhibit D-aspartate uptake and increase the accumulation of glutamate at the extracellular space, suggesting that both compounds interfere with the functioning of a glutamate transporter in retinal cells. It is important to highlight that the increase in extracellular glutamate is not promoted by a cell death process, since we have not detected any increase in MTT in the incubation period of 30 min. Furthermore, our results show that the inhibitory effect was detected in purified neuronal cultures but not in purified glial cultures. This decrease in [ 3 H] D-aspartate uptake in neurons correlates with a decrease in EAAT3 levels promoted by ascorbate. However, this observation does not exclude the possibility that ascorbate is also regulating the transport mediated by other different EAAT subtypes. Interestingly, different from the inhibition of [ is inhibiting a glutamate transporter and not increasing glutamate release. In addition, Agostinho et al. (1997) reported that ascorbate, in the presence of Fe 2+ , could inhibit glutamate transport through a mechanism related to the Fenton reaction. It was also shown that DTNB, a thiol oxidant, decreases, while DTT, an anti-oxidant, increases glutamate uptake, suggesting that the glutamate transporters may be regulated by a redox mechanism (Trotti et al. 1997) . However, in our present study we observed that both ascorbate and DHA inhibit glutamate uptake. Indeed, Baek et al. (2016) showed that high concentrations of ascorbate increase protein kinase C activity, and this kinase appears to regulate EAATs membrane levels, therefore regulating in this way glutamate uptake (Trotti et al. 2001; L opez-Bayghen and Ortega 2004; Garcia-Tardon et al. 2012) . We then cannot exclude the possibility that ascorbate is regulating protein kinase C activity and consequently regulating the transport of glutamate in our experimental model. (1.5 mM; n = 3), dehydroascorbate (DHA) (1.5 mM; n = 3), glutathione (GSH) (1.5 mM; n = 3) or dithiothreitol (DTT) (1.5 mM; n = 4) for 30 min and then processed for western blot against pCREB Ser133. (e and f) ex vivo retinas from 12-day-old chick embryos were incubated in the absence (control, CT) or presence of ascorbate (1.5 mM; n = 3) for 30 min and then tissues were processed for western blot against pCREB Ser133. Each n represents the mean AE SEM of independent cultures. *p < 0.05, **p < 0.01 in relation to control Activation of NMDA receptors by vitamin C It was suggested that ascorbate might directly interact with NMDA receptors to decrease their function in cortical neurons (Majewska et al. 1990 ). This effect could be due to a direct binding to the redox site on the NMDA receptor (Aizenman et al. 1989; Leszkiewicz and Aizenman 2002; Talukder et al. 2011) . Furthermore, it is also interesting to note that reducing agents such as DTT (Aizenman 1995) are described to increase NMDA receptor function, while oxidizing agents such as DNTB classically decrease NMDA receptor currents (Gozlan et al. 1994; Yamakura and Shimoji 1999) . However, we have shown here that vitamin C, either in its oxidized (DHA) or reduced form (ascorbate), regulates [ 3 H] MK-801 binding to NMDA receptors. Interestingly, these effects by the vitamin C forms were only a small fraction of that observed with glutamate itself. This suggests that the effect of vitamin C is mediated through an indirect mechanism. Our hypothesis is that vitamin C inhibits glutamate uptake and accumulates glutamate in the extracellular medium, thereby activating NMDA as well as other glutamate receptors expressed by retinal cells.
Modulation of NMDA receptor expression by vitamin C Our biotinylation and confocal microscopy data showed that ascorbate induces an internalization of GluN1-containing NMDA channels at the neuronal plasma membrane. The process of ionotropic receptor downregulation is classically associated with long-term receptor activation and then ligand-induced downregulation is prone to occur in GluN1-containing NMDA channels. This downregulation induced by vitamin C could explain why the treatment with ascorbate or DHA did not stimulate [ 3 H] MK-801 binding to the same level as glutamate alone. Interestingly, incubation with either compound together with glutamate reduced the binding induced by this amino acid to the level obtained with vitamin C alone. One possibility to explain these results would be the vitamin C regulation of the surface expression of NMDA receptors. The mechanisms involved in this phenomenon are presently unknown, but this finding points to a very important function of vitamin C on glutamate signaling in the retina. Further experiments are needed to clarify if vitamin C changes the levels of other NMDA receptor subunits in the membrane such as GluN2A or GluN2B, and if it would be subunit-specific or not.
Ascorbate modulates NMDA receptor-dependent signaling pathways We hypothesized that ascorbate increases the extracellular content of glutamate, which could in turn promote the activation of NMDA and AMPA/kainate receptors, leading to downstream signaling pathways. Indeed, ascorbate as well as DHA promote CREB phosphorylation in retinal cultures and this effect was blocked by the NMDA blocker MK801 and partially by the AMPA/Kainate antagonist DNQX. This is consistent with the hypothesis mentioned above that glutamate accumulation in the extracellular space could activate AMPA receptors leading to opening of NMDA channels. It has been described that the activation of extrasynaptic receptors opposes to the activation of synaptic NMDA receptors and triggers apoptotic cell death in cultured ,7-dinitroquinoxaline-2,3-dione (DNQX) (100 lM; n = 4) or sulfinpyrazone (1 mM; n = 4) for 10 min, incubated in the absence (control, CT) or presence of ascorbate (1.5 mM; n = 17) for 30 min and then processed for western blot against pCREB Ser133. (c and d) cells were pretreated with KN 62 (10 lM; n = 5) or BAPTA-AM (10 lM; n = 4), incubated in the absence (control, CT) or presence of ascorbate (1.5 mM) for 30 min and then processed for western blot against pCREB Ser133. Each n represents the mean AE SEM of independent cultures. ***p < 0.001, ****p < 0.0001 in relation to control;°p < 0.05,°°°p < 0.001 in relation to ascorbate. Fig. 9 Model of vitamin C modulation of the glutamatergic system. Directly or indirectly, vitamin C inhibits the glutamate transport system in chick embryo retina cultures. This inhibition increases the concentration of extracellular glutamate which in turn increases NMDA and/or 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid (AMPA)/Kainate receptor activity. Therefore, we observed an increase in CaMK-dependent cAMP response elementbinding protein (CREB) phosphorylation. It was also observed a decrease in membrane NMDA receptor levels, but not total receptor expression. Figure created in the Mind the Graph platform (www.mindthegraph.com).
hippocampal neurons (Hardingham et al. 2002; Hardingham and Bading 2010) . In addition, activation of synaptic NMDA receptors increases CREB phosphorylation and extra-synaptic NMDA receptors decrease CREB phosphorylation (Hardingham et al. 2002) . Here, we show that 30 min of treatment with ascorbate increases CREB phosphorylation up to 60 min, suggesting that in our paradigm, synaptic NMDA receptors would be predominantly activated. More experiments are needed to investigate whether chronic treatment with ascorbate would inhibit EAAT function in such a way that it could promote glutamate spillover, leading to cell death by overactivation of NMDA receptors.
Noteworthy, the effect of ascorbate was not blocked by the SVCT2 inhibitor sulfinpyrazone, further indicating that the effect is not mediated by the uptake of ascorbate. Activation of NMDA receptors is known to increase calcium influx, activation of calcium-dependent signaling pathways, and CREB phosphorylation (Takeda et al. 2007) . The participation of calcium and calcium/calmodulin-dependent kinases in CREB phosphorylation induced by ascorbate in our cultures is also consistent with the hypothesis of participation of NMDA receptors. Nevertheless, despite the indication that CREB phosphorylation was strongly regulated by calcium signaling through CaMK in our paradigm, it is not possible to exclude the possibility that other signaling proteins could be participating in this process.
In conclusion, the present work showed that vitamin C modulates glutamatergic signaling in retinal cells. As depicted in Fig. 9 , vitamin C inhibits glutamate uptake and promotes glutamate accumulation at the extracellular space. These events produce a subsequent activation of NMDA and or AMPA/Kainate receptors and calcium-dependent downstream signaling pathways such as calmodulin-dependent kinases and CREB. These results strongly suggest that vitamin C works as a neuromodulator in the retina. Taking account that the glutamatergic neurotransmission in the developing retina is of prime importance for its normal function, we suggest therefore that ascorbate may have a profound influence on excitatory signaling in the developing retina. Further experiments are needed to investigate if vitamin C is still able to modulate the glutamatergic system in mature neurons.
